SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Do Not Trade on Beta Ratings - these are in Testing - and purposely being Randomized - Repeat - Do Not Trade on Ratings - In Testing - Thank you!
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
BIOSANTE PHARMACEUTICALS
(NQNM:BPAX Last Sale: 1.14 -.01)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (BPAX : $1.14)
$31 million Market Cap at May 22, 2013
Employs 11.
Biomedics SubIndustry down < .25%> / Health Industry down < .08> Today

111 Barclay Boulevard Research Report Earnings Snapshot - Last 05/10/13
Lichonshire, IL 60069 Annual Reports
Phone: (847) 793-2458

Louis W. Sullivan, Chmn., Stephen M. Simes, Vice Chmn./Pres./CEO, Phillip B. Donenberg, CFO
Develops nanoparticulate-based platform technology for novel vaccines, vaccine adjuvants and drug delivery systems. Reverse split 1-for-10 and symbol change to BISP June 3, 2002.
Historical Charts    Technical Analysis    IntraDay Charts

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common BPAX $1.14 $1.15 -.01 -.9 $1.12 $1.16 176,638 $1.01 $3.6549 27,043
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10066
Common Stock $30,829

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
05-NOV-07 BPA Symbol Changed to BPAX
26-SEP-03 BTPH Symbol Changed to BPA
15-DEC-99 BNHT Symbol Changed to BTPH

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2013 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex